Anthony Hayes A Ikido Pharma Inc. (AIKI) insider trading activity

AIKI Quotes by TradingView

Anthony Hayes is CEO of AIkido Pharma Inc.. Currently has a direct ownership of 1.75 Million shares of AIKI, which is worth approximately $6.65 Million. The most recent transaction as insider was on Aug 26, 2022, when has been sold 78,588 shares (Common Stock) at a price of $6.0 per share, resulting in proceeds of $471,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.75M
8.44% 3M change
154.92% 12M change
Total Value Held $6.65 Million

Anthony Hayes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2022
BUY
Grant, award, or other acquisition
$471,528 $6.0 p/Share
78,588 Added 48.33%
84,016 Common Stock
May 03 2021
BUY
Open market or private purchase
$9,900 $0.99 p/Share
10,000 Added 11.31%
78,430 Common Stock
Apr 29 2021
BUY
Open market or private purchase
$9,900 $0.99 p/Share
10,000 Added 12.75%
68,430 Common Stock
Apr 22 2021
BUY
Open market or private purchase
$9,300 $0.93 p/Share
10,000 Added 14.61%
58,430 Common Stock
AH

Anthony Hayes

CEO
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIKI